{"celex_id": "31995R2796", "uri": "http://publications.europa.eu/resource/cellar/a26cb77e-55ab-4547-b33e-a8f24a9e25d5", "type": "Regulation", "concepts": ["1442", "192", "2737", "343", "5734"], "title": "Commission Regulation (EC) No 2796/95 of 4 December 1995 amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)\n", "header": "5.12.1995 EN Official Journal of the European Communities L 290/1\nCOMMISSION REGULATION (EC) No 2796/95\nof 4 December 1995\namending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\n(Text with EEA relevance)\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\u00a0(1), as last amended by Commission Regulation (EC) No 1798/95\u00a0(2), and in particular Articles 7 and 8 thereof,\nWhereas, in accordance with Regulation (EEC) No 2377/90, the maximum residue limits must be established progressively for all pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals;\nWhereas maximum residue limits should be established only after the examination within the Committee for Veterinary Medicinal Products of all the relevant information concerning the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs;\nWhereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue);\nWhereas, for the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established for the target tissues of liver or kidney; whereas, however, the liver and kidney are frequently removed from carcasses moving in international trade, and maximum residue limits should therefore also always be established for muscle or fat tissues;\nWhereas, in the case of veterinary medicinal products intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey;\nWhereas, a number of pharmacologically active substances are generally recognized as safe; whereas these substances should be inserted into Annex II of Regulation (EEC) No 2377/90;\nWhereas, substances used in homeopathic veterinary medicinal products shall be inserted into Annex II of Regulation (EEC) No 2377/90 provided that their concentration does not exceed one part per 10\u00a0000;\nWhereas a period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjustment which may be necessary to the authorizations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Council Directive 81/851/EEC\u00a0(3), as last amended by Directive 93/40/EEC\u00a0(4) to take account of the provisions of this Regulation;\nWhereas the measures provided for in this Regulation are in accordance with the opinion of the Committee for the Adaptation to Technical Progress of the Directives on the Removal of Technical Barriers to Trade in the Veterinary Medicinal Products Sector,", "main_body": ["Annex II of Regulation (EEC) No 2377/90 is hereby amended as set out in the Annex hereto.", "This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 4 December 1995.\nFor the Commission\nMartin BANGEMANN\nMember of the Commission\n(1)\u00a0\u00a0OJ No L 224, 18. 8. 1990, p. 1.\n(2)\u00a0\u00a0OJ No L 174, 27. 7. 1995, p. 20.\n(3)\u00a0\u00a0OJ No L 317, 6. 11. 1981, p. 1.\n(4)\u00a0\u00a0OJ No L 214, 24. 8. 1993, p. 31.\nANNEX\nAnnex II is modified as follows\n\u20183. Substances generally recognized as safe\nPharmacologically active substances Animal species Other provisions\n3.1. Absinthium extract\n3.2. Acetylmethionine\n3.3. Aluminium hydroxide\n3.4. Aluminium monostearate\n3.5. Ammonium sulfate\n3.6. Benzoyl benzoate\n3.7. Benzyl p-hydroxybenzoate\n3.8. Calcium borogluconate\n3.9. Calcium citrate\n3.10. Camphor\n3.11. Cardamon extract\n3.12. Diethyl sebacate\n3.13. Dimethicone\n3.14. Dimethyl acetamide\n3.15. Dimethyl sulphoxide\n3.16. Ethylenediaminetetraacetic acid and salts\n3.l7. Eucalyptol\n3.18. Epinephrine\n3.19. Ethyl oleate\n3.20. Formaldehyde\n3.21. Formic acid\n3.22. Follicle stimulating hormone (natural FSH from all species and their synthetic analogues)\n3.23. Glutaraldehyde\n3.24. Guaiacol\n3.25. Heparin and its salts\n3.26. Human chorionic gonadotropin (natural HCG and its synthetic analogues)\n3.27. Iron ammonium citrate\n3.28. Iron dextran\n3.29. Iron glucoheptonate\n3.30. Isopropanol\n3.31. Lanolin\n3.32. Luteinizing hormone (natural LH from all species and their synthetic analogues)\n3.33. Magnesium chloride\n3.34. Magnesium gluconate\n3.35. Magnesium hypophosphite\n3.36. Mannitol\n3.37. Montanide\n3.38. Methylbenzoate\n3.39. Monothioglycerol\n3.40. Myglyol\n3.41. Orgotein\n3.42. Poloxalene\n3.43. Poloxamer\n3.44. Polyethylene glycol 200\n3.45. Polyethylene glycol 400\n3.46. Polyethylene glycol 600\n3.47. Polyethylene glycol 3500\n3.48. Polysorbate 80\n3.49. Serotonin\n3.50. Sodium chloride\n3.51. Sodium cromoglycate\n3.52. Sodium dioctylsulphosuccinate\n3.53. Sodium formaldehydesulphoxylate\n3.54. Sodium lauryl sulphate\n3.55. Sodium pyrosulphite\n3.56. Sodium stearate\n3.57. Sodium thiosulphate\n3.58. Tragacanth\n3.59. Urea\n3.60. Zinc sulphate\n3.61. Zinc oxide\n4. Substances used in homeopathic veterinary medicinal products\nPharmacologically active substance(s) Animal species Other provisions\n4.1. Any substance used in veterinary homeopathic medicinal products provided that its concentration in the product does not exceed one part per 10\u00a0000"}